Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 07, 2023

BUY
$191.51 - $216.16 $383,020 - $432,320
2,000 Added 153.85%
3,300 $40,000
Q2 2023

Jul 18, 2023

BUY
$187.64 - $206.25 $243,931 - $268,125
1,300 New
1,300 $4,000
Q3 2022

Oct 25, 2022

SELL
$135.27 - $180.11 $1.01 Million - $1.35 Million
-7,500 Reduced 77.32%
2,200 $4,000
Q2 2022

Aug 04, 2022

SELL
$108.81 - $179.33 $97,929 - $161,397
-900 Reduced 8.49%
9,700 $171,000
Q4 2021

Jan 18, 2022

BUY
$142.57 - $190.86 $1.51 Million - $2.02 Million
10,600 New
10,600 $33,000

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.